|
Drug Name
|
|
Anticancer Agents
|
|
|
Anticancer Agents
|
|
|
ABRAXANE INTRAVENOUS SUSPENSION FOR RECONSTITUTION 100 MG
|
|
|
ADCETRIS INTRAVENOUS RECON SOLN 50 MG
|
|
|
ALIQOPA INTRAVENOUS RECON SOLN 60 MG
|
|
|
ARZERRA INTRAVENOUS 100 MG (OFATUMUMAB)
|
|
|
cyclophosphamide oral capsule 25 MG, 50 MG
|
|
|
cyclophosphamide oral tablet25 mg, 50 mg
|
|
|
CYRAMZA INTRAVENOUS SOLUTION 10 MG/ML
|
|
|
DARZALEX FASPRO SUBCUTANEOUS SOLUTION 1,800 MG-30,000 UNIT/15 ML
|
|
|
DARZALEX INTRAVENOUS SOLUTION 20 MG/ML
|
|
|
EMPLICITI INTRAVENOUS RECON SOLN 300 MG, 400 MG
|
|
|
ERBITUX INTRAVENOUS SOLUTION 100 MG/50 ML, 200 MG/100 ML
|
|
|
fulvestrant intramuscular syringe 250 mg/5 ml
|
(Faslodex)
|
|
GAZYVA INTRAVENOUS SOLUTION 1,000 MG/40 ML
|
|
|
HALAVEN INTRAVENOUS 1 MG (ERIBULIN MESYLATE)
|
|
|
HERCEPTIN HYLECTA SUBCUTANEOUS SOLUTION 600 MG-10,000 UNIT/5 ML
|
|
|
HERCEPTIN INTRAVENOUS RECON SOLN 150 MG
|
|
|
ISTADOX INTRAVENOUS 10 MG (ROMIDEPSIN)
|
|
|
IXEMPRA INTRAVENOUS RECON SOLN 15 MG, 45 MG
|
|
|
KADCYLA (ADO-TRASTUZUMAB EMTANSINE)
|
|
|
KEYTRUDA INTRAVENOUS SOLUTION 25 MG/ML
|
|
|
KYPROLIS INTRAVENOUS RECON SOLN 10 MG, 30 MG, 60 MG
|
|
|
MARQIBO (VINCRISTINE SULFATE LIPOSOME)
|
|
|
OPDIVO INTRAVENOUS SOLUTION 100 MG/10 ML, 240 MG/24 ML, 40 MG/4 ML
|
|
|
RITUXAN HYCELA SUBCUTANEOUS SOLUTION 1400 MG/11.7 ML (120 MG/ML), 1600 MG/13.4 ML (120 MG/ML)
|
|
|
RITUXAN INTRAVENOUS CONCENTRATE 10 MG/ML
|
|
|
TECENTRIQ INTRAVENOUS SOLUTION 1,200 MG/20 ML (60 MG/ML), 840 MG/14 ML (60 MG/ML)
|
|
|
VELCADE INJECTION RECON SOLN 3.5 MG
|
|
|
XATMEP ORAL SOLUTION 2.5 MG/ML
|
|
|
YERVOY INTRAVENOUS SOLUTION 200 MG/40 ML (5 MG/ML), 50 MG/10 ML (5 MG/ML)
|
|
|
YONDELIS INTRAVENOUS RECON SOLN 1 MG
|
|
|
ZALTRAP INTRAVENOUS 100 MG (ZIV-AFLIBERCEPT)
|
|
|
Central Nervous System Agents
|
|
|
Central Nervous System Agents
|
|
|
RADICAVA INTRAVENOUS SOLUTION 30 MG/100 ML
|
|
|
Enzyme Replacement/Modifiers
|
|
|
Enzyme Replacement/Modifiers
|
|
|
PEGLOTICASE INTRAVENOUS SOLUTION 8 MG/ML
|
(Krystexxa)
|
|
Immunological Agents
|
|
|
Immunological Agents
|
|
|
AVSOLA INTRAVENOUS 100 MG (INFLIXIMAB-AXXQ)
|
|
|
CINQAIR INTRAVENOUS 100 MG (RESLIZUMAB)
|
|
|
FASENRA SUBCUTANEOUS 30 MG (BENRALIZUMAB)
|
|
|
INFLECTRA INTRAVENOUS 100 MG (INFLIXIMAB-DYYB)
|
|
|
IXIFI INTRAVENOUS 100 MG (INFLIXIMAB-QBTX)
|
|
|
PROGRAF ORAL GRANULES IN PACKET 0.2 MG, 1 MG
|
|
|
RENFLEXIS INTRAVENOUS 100 MG (INFLIXIMAB-ABDA)
|
|
|
Metabolic Bone Disease Agents
|
|
|
Metabolic Bone Disease Agents
|
|
|
DENOSUMAB SUBCUTANEOUS SYRINGE 60 MG/ML
|
(Prolia)
|
|
DENOSUMAB SUBCUTANEOUS SOLUTION 120 MG/1.7 ML (70 MG/ML)
|
(Xgeva)
|
|
DUROLANE INTRAARTICULAR 60 MG (HYALURONATE SODIUM)
|
|
|
EUFLEXXA INTRAARTICULAR 20 MG (HYALURONATE SODIUM)
|
|
|
GEL-ONE INTRAARTICULAR 30 MG (HYALURONATE SODIUM)
|
|
|
GELSYN-3 INTRAARTICULAR 16.8MG (HYALURONATE SODIUM)
|
|
|
GENVISC 850 INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
HYALGAN INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
HYMOVIS INTRAARTICULAR 8 MG (HYALURONATE SODIUM)
|
|
|
MONOVISC INTRAARTICULAR 88 MG (HYALURONATE SODIUM)
|
|
|
ORTHOVISC INTRAARTICULAR 30 MG (HYALURONATE SODIUM)
|
|
|
SUPARTZ INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
SUPARTZ FX INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
SYNVISC INTRAARTICULAR (HYALURONATE SODIUM)
|
|
|
SYNVISC-ONE INTRAARTICULAR (HYALURONATE SODIUM)
|
|
|
TRILURON INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
TRIVISC INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
VISCO-3 INTRAARTICULAR 10 MG (HYALURONATE SODIUM)
|
|
|
zoledronic acid intravenous recon soln 4 mg
|
|
|
zoledronic acid intravenous solution 4 mg/5 ml
|
|
|
zoledronic acid-mannitol-water intravenous piggyback 5 mg/100 ml
|
(Reclast)
|
|
Miscellaneous Therapeutic Agents
|
|
|
Miscellaneous Therapeutic Agents
|
|
|
CRYSVITA SUBCUTANEOUS 10 MG (BUROSUMAB-TWZA)
|
|
|
CRYSVITA SUBCUTANEOUS 20 MG (BUROSUMAB-TWZA)
|
|
|
CRYSVITA SUBCUTANEOUS 30 MG (BUROSUMAB-TWZA)
|
|
|
BOTOX INJECTION 100 UNIT (ONABOTULINUMTOXINA)
|
|
|
BOTOX INJECTION 200 UNIT (ONABOTULINUMTOXINA)
|
|
|
DYSPORT INJECTION 300 UNIT (ABOBOTULINUMTOXINA)
|
|
|
DYSPORT INJECTION 500 UNIT (ABOBOTULINUMTOXINA)
|
|
|
MYOBLOC INJECTION 2500 UNIT (RIMABOTULINUMTOXINB)
|
|
|
MYOBLOC INJECTION 5000 UNIT (RIMABOTULINUMTOXINB)
|
|
|
MYOBLOC INJECTION 10000 UNIT (RIMABOTULINUMTOXINB)
|
|
|
XEOMIN INJECTION 50 UNIT (INCOBOTULINUMTOXINA)
|
|
|
XEOMIN INJECTION 100 UNIT (INCOBOTULINUMTOXINA)
|
|
|
XEOMIN INJECTION 200 UNIT (INCOBOTULINUMTOXINA)
|
|
|
Respiratory Tract Agents
|
|
|
Respiratory Tract Agents, Other
|
|
|
NUCALA SUBCUTANEOUS AUTO-INJECTOR 100 MG/ML
|
|
|
NUCALA SUBCUTANEOUS RECON SOLN 100 MG
|
|
|
NUCALA SUBCUTANEOUS SYRINGE 100 MG/ML
|
|
|
XOLAIR SUBCUTANEOUS RECON SOLN 150 MG
|
|
|
XOLAIR SUBCUTANEOUS SYRINGE 150 MG/ML, 75 MG/0.5 ML
|
|